Saturday, October 31, 2026

BlackRock And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

BlackRock  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - RF Industries, Ltd. (RFIL), Hyster (HY), Nasdaq (NDAQ) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. RF Industries, Ltd. (RFIL)

45.2% sales growth and 13.11% return on equity

RF Industries, Ltd., together with its subsidiaries, designs, manufactures, and markets interconnect products and systems in the United States, Canada, Mexico, and internationally.

RF Industries, Ltd.'s sales growth this year is expected to be 16.3% and 50.4% for next year.

Year-on-year quarterly revenue growth grew by 6.4%, now sitting on 41.3M for the twelve trailing months.

Volume

Today's last reported volume for RF Industries, Ltd. is 14522 which is 79.87% below its average volume of 72134.

RF Industries, Ltd.'s sales growth is a negative 0% for the present quarter and 45.2% for the next. The company's growth estimates for the current quarter and the next is 300% and 175%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.11%.

Volatility

RF Industries, Ltd.'s last day, last week, and last month's current volatility was 0.53%, 1.00%, and 1.51%, respectively.

RF Industries, Ltd.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.06% (day), 2.31% (last week), and 3.41% (last month), respectively.

RF Industries, Ltd.'s Stock Yearly Top and Bottom Value

RF Industries, Ltd.'s stock is valued at $7.30 at 05:22 EST, way below its 52-week high of $8.67 and way above its 52-week low of $4.05.

RF Industries, Ltd.'s Moving Average

RF Industries, Ltd.'s worth is below its 50-day moving average of $7.58 and way above its 200-day moving average of $6.39.

2. Hyster (HY)

16.8% sales growth and 5.01% return on equity

Hyster-Yale Materials Handling, Inc., through its subsidiaries, designs, engineers, manufactures, sells, and services a line of lift trucks, attachments, and aftermarket parts worldwide.

Hyster's sales growth this year is anticipated to be 10.7% and 6.8% for next year.

Year-on-year quarterly revenue growth declined by 6.8%, now sitting on 2.76B for the twelve trailing months.

Volume

Today's last reported volume for Hyster is 19409 which is 58.01% below its average volume of 46225.

Hyster's sales growth for the next quarter is 16.8%. The company's growth estimates for the current quarter and the next is a negative 56% and negative -41.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.01%.

Volatility

Hyster's last day, last week, and last month's current volatility was 3.88%, 2.57%, and 2.80%, respectively.

Hyster's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.75% (day), 3.54% (last week), and 4.45% (last month), respectively.

Hyster's Stock Yearly Top and Bottom Value

Hyster's stock is valued at $71.56 at 05:22 EST, way below its 52-week high of $102.17 and way higher than its 52-week low of $34.52.

Hyster's Moving Average

Hyster's value is under its 50-day moving average of $73.44 and way under its 200-day moving average of $80.35.

3. Nasdaq (NDAQ)

12.2% sales growth and 17.52% return on equity

Nasdaq, Inc. operates as a technology company that serves capital markets and other industries worldwide.

Nasdaq's sales growth this year is expected to be 13.3% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 22.1%, now sitting on 5.93B for the twelve trailing months.

Volume

Today's last reported volume for Nasdaq is 641933 which is 14.05% below its average volume of 746847.

Nasdaq's sales growth is a negative 0% for the current quarter and 12.2% for the next. The company's growth estimates for the ongoing quarter and the next is 9.1% and 5.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.52%.

Volatility

Nasdaq's last day, last week, and last month's current volatility was 0.11%, 0.55%, and 0.73%, respectively.

Nasdaq's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.13% (day), 1.19% (last week), and 1.30% (last month), respectively.

Nasdaq's Stock Yearly Top and Bottom Value

Nasdaq's stock is valued at $174.08 at 05:22 EST, under its 52-week high of $180.53 and way higher than its 52-week low of $118.01.

Nasdaq's Moving Average

Nasdaq's worth is higher than its 50-day moving average of $171.95 and way above its 200-day moving average of $153.18.

Previous days news about Nasdaq(NDAQ)

According to Bloomberg Quint on Sunday, 4 July, "Indeed, the Nasdaq 100 Index has reached an overbought level, which over the past year led to some declines in the short term."

According to Business Insider on Sunday, 4 July, "Biotech stocks underperformed the broader market in the first half of 2021, with theiShares Nasdaq Biotechnology ETF (NASDAQ:IBB) advancing about 8% year-to-datecompared to the roughly 14% gain for the S&P 500 Index."

4. BlackRock (BLK)

9.6% sales growth and 16.4% return on equity

BlackRock, Inc. is a publicly owned investment manager.

BlackRock's sales growth this year is expected to be 16.4% and 9.6% for next year.

Year-on-year quarterly revenue growth grew by 18.5%, now sitting on 16.89B for the twelve trailing months.

Volume

Today's last reported volume for BlackRock is 602696 which is 13.85% above its average volume of 529379.

BlackRock's sales growth for the next quarter is 9.6%. The company's growth estimates for the current quarter and the next is 18% and 6.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.4%.

Volatility

BlackRock's last day, last week, and last month's current volatility was 0.93%, 0.67%, and 0.84%, respectively.

BlackRock's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.44% (day), 1.18% (last week), and 1.37% (last month), respectively.

BlackRock's Stock Yearly Top and Bottom Value

BlackRock's stock is valued at $876.50 at 05:22 EST, below its 52-week high of $902.72 and way higher than its 52-week low of $531.39.

BlackRock's Moving Average

BlackRock's value is higher than its 50-day moving average of $873.68 and way above its 200-day moving average of $784.39.

Previous days news about BlackRock(BLK)

According to CNBC on Monday, 5 July, "The three largest shareholders - Silchester, BlackRock and Columbia Threadneedle - cumulatively account for more than 35% of shares and have yet to publicly comment on the Fortress proposal."

Fidelity, BlackRock lead fintech startup’s $600 million funding. According to Bloomberg Quint on Tuesday, 6 July, "Pine Labs Pvt, a payments platform for merchants in India and Southeast Asia, closed a $600 million fundraising round with some of the world's largest investors including Fidelity Management & Research Co. and BlackRock Inc. as it targets a public offering within 18 months."

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com